How should I treat an 18‑year‑old male with uncomplicated urogenital Chlamydia trachomatis infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Uncomplicated Chlamydia in an 18-Year-Old Male

Treat immediately with either azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days—both achieve 97-98% cure rates and are equally effective first-line options. 1

First-Line Treatment Options

Azithromycin 1 g single oral dose is preferred when:

  • Compliance is uncertain or follow-up unpredictable 1
  • Directly observed therapy is desired 2, 1
  • The patient has erratic health-care-seeking behavior 1

Doxycycline 100 mg orally twice daily for exactly 7 days is equally effective and offers:

  • Lower cost than azithromycin 1
  • Superior efficacy for rectal chlamydia (94% vs 85% cure rate) 1, 3
  • Extensive clinical experience 1

Both regimens should be dispensed on-site when possible, with the first dose directly observed to maximize compliance. 2, 1

Mandatory Sexual Abstinence and Partner Management

  • The patient must abstain from all sexual intercourse for 7 days after initiating treatment and until all symptoms have resolved 1, 3
  • All sex partners from the preceding 60 days must be evaluated, tested, and treated empirically with the same regimen, even if asymptomatic 1, 3
  • Partners should receive treatment without waiting for their own test results because sex partners of infected patients have substantially increased risk 1

Concurrent Gonorrhea Testing and Treatment

  • Test for gonorrhea via NAAT at the initial visit 1
  • If gonorrhea is confirmed or prevalence exceeds 5% in your population, treat concurrently with ceftriaxone 250 mg IM single dose PLUS azithromycin 1 g orally single dose 1, 3
  • Coinfection rates range from 20-40% in high-prevalence populations 1, 3

Additional STI Screening

All patients diagnosed with chlamydia should be tested for:

  • Syphilis 1
  • HIV 2, 1

Follow-Up Recommendations

Test-of-cure is NOT recommended for asymptomatic men treated with recommended regimens because cure rates exceed 97%. 1 Testing before 3 weeks may yield false-positive results from residual DNA. 1

Repeat testing at 3 months is strongly recommended to detect reinfection, which occurs in up to 39% of cases and carries elevated risk for complications. 1 This should be done regardless of whether partners were reportedly treated. 1

Alternative Regimens (Only if First-Line Agents Cannot Be Used)

If azithromycin and doxycycline are contraindicated:

  • Erythromycin base 500 mg orally four times daily for 7 days 2, 1
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 2, 1
  • Ofloxacin 300 mg orally twice daily for 7 days 2, 1
  • Levofloxacin 500 mg orally once daily for 7 days (88-94% cure rate vs 97-98% for first-line agents) 1

Note: Erythromycin has poor compliance due to gastrointestinal side effects and is less efficacious than first-line agents. 1 Fluoroquinolones offer no compliance advantage over doxycycline, are more expensive, and have inferior evidence. 1

Management of Persistent or Recurrent Symptoms

Do NOT retreat based on symptoms alone—require objective evidence of urethral inflammation (≥5 WBC per high-power field on urethral Gram stain or ≥10 WBC per high-power field on first-void urine microscopy). 1

If symptoms persist after completing therapy:

  • Consider testing for Mycoplasma genitalium using NAAT on first-void urine or urethral swab 4
  • M. genitalium responds poorly to doxycycline (30-40% cure rate) but better to azithromycin (85-95% for susceptible strains) 4
  • For macrolide-resistant M. genitalium, use moxifloxacin 400 mg orally once daily for 7 days 4

Critical Pitfalls to Avoid

  • Do NOT wait for test results before treating in high-risk populations with uncertain follow-up 1
  • Do NOT assume partners were treated—directly verify or use expedited partner therapy 1
  • Do NOT perform test-of-cure in asymptomatic patients treated with recommended regimens, as this wastes resources 1
  • Do NOT use fluoroquinolones or tetracyclines in pregnancy—these are absolutely contraindicated 1, 3

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Doxycycline in STDs: Target Organisms and Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Testing for Mycoplasma genitalium in Males

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.